Skip to main content

Together we are beating cancer

Donate now

Lung cancer

Lung cancer is the third most common cancer in the UK, with around 48,500 people diagnosed each year. There are two main types of lung cancer – small cell lung cancer and non small cell lung cancer – depending on how the cells look under the microscope.

The main symptoms are a cough, shortness of breath and weight loss.

Showing 12 out of 355 results
Cancer Research UK logo

Elderly patients with advanced non small cell lung cancer (NSCLC) who developed a rash within 28 days of receiving the targeted drug erlotinib (Tarceva) survived on average 6.2 months, compared to 4.1 months for patients who were given a placebo, results from a major phase III Cancer Research UK-funded trial show today (Tuesday). Elderly patients with advanced non small cell lung cancer (NSCLC) who developed a rash within 28 days of receiving the targeted drug erlotinib (Tarceva) survived on average 6.2 months, compared to 4.1 months for patients who were given a placebo, results from a major phase III Cancer Research UK-funded trial show today (Tuesday).

by Cancer Research UK | News | 16 October 2012

16 October 2012

Cancer Research UK logo

Three recent studies underline the need for action on tobacco marketing, such as forcing tobacco companies to sell their wares in plain packs. Three recent studies underline the need for action on tobacco marketing, such as forcing tobacco companies to sell their wares in plain packs.

by Henry Scowcroft | Analysis | 7 August 2012

7 August 2012

Cancer Research UK logo

Around 8,000 cancer deaths in Britain each year are linked to occupations - especially those where asbestos, diesel engine fumes or shift work is involved - a new study shows today. This equates to around 5 per cent of all cancer deaths in Britain. Around 8,000 cancer deaths in Britain each year are linked to occupations - especially those where asbestos, diesel engine fumes or shift work is involved - a new study shows today. This equates to around 5 per cent of all cancer deaths in Britain.

by British Journal of Cancer | News | 20 June 2012

20 June 2012

Car exhaust.

We speak to our carcinogen expert Professor David Phillips about this week's announcement by IARC that diesel exhaust fumes cause lung cancer. We speak to our carcinogen expert Professor David Phillips about this week's announcement by IARC that diesel exhaust fumes cause lung cancer.

by Henry Scowcroft | Analysis | 14 June 2012

14 June 2012

Cancer Research UK logo

A Cancer Research UK initiative to improve cancer gene testing has prompted two pharmaceutical companies to plan pioneering international trials into targeted cancer treatments in the UK. A Cancer Research UK initiative to improve cancer gene testing has prompted two pharmaceutical companies to plan pioneering international trials into targeted cancer treatments in the UK.

by Cancer Research UK | News | 31 May 2012

31 May 2012

Cancer Research UK logo

Cancer Research UK’s Drug Development Office has opened the first trial of a new drug combination in patients with advanced solid tumours and in a subset of patients who have non-small cell lung cancer. This trial will combine two compounds that aim to starve the tumours while simultaneously blocking cancer cell growth. Cancer Research UK’s Drug Development Office has opened the first trial of a new drug combination in patients with advanced solid tumours and in a subset of patients who have non-small cell lung cancer. This trial will combine two compounds that aim to starve the tumours while simultaneously blocking cancer cell growth.

by Cancer Research UK | News | 17 May 2012

17 May 2012

Cancer Research UK logo

Hear the first hand experience of a lung cancer nurse, from what it's like to care for patients to the importance of reducing smoking to help fight the disease. Hear the first hand experience of a lung cancer nurse, from what it's like to care for patients to the importance of reducing smoking to help fight the disease.

by Paul Thorne | Analysis | 14 May 2012

14 May 2012

Cancer Research UK logo

A common cancer drug and a drug used for a rare condition affecting the heart could together treat an aggressive form of lung cancer called non-small cell lung cancer (NSCLC), according to a study published in Cell today A common cancer drug and a drug used for a rare condition affecting the heart could together treat an aggressive form of lung cancer called non-small cell lung cancer (NSCLC), according to a study published in Cell today

by Cancer Research UK | News | 26 April 2012

26 April 2012